AMS Bulking Out Stress Incontinence Offerings Via UroVive Acquisition
This article was originally published in The Gray Sheet
American Medical Systems and UroSurge expect to complete by year-end a modular premarket approval application submission for the UroVive urethral bulking agent system. AMS agreed to acquire the product from UroSurge on July 26.
You may also be interested in...
A planned initial public offering by American Medical Systems Holdings, Inc., maker of urological disorder treatment devices, is anticipated to raise $68.8 mil. -including $40 mil. tabbed to "repay all of the outstanding debt under the guaranteed portion" of a $115 mil. credit facility.
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.